Molecule Details
| InChIKey | SFSVYOSUWJRGTM-MHZLTWQESA-N |
|---|---|
| Compound Name | (2S)-2-({1-[benzyl(1,3-thiazol-5-ylmethyl)carbamoyl]-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl}formamido)-4-(methylsulfanyl)butanoic acid |
| Canonical SMILES | CSCC[C@H](NC(=O)C1=C(c2ccccc2C)CN(C(=O)N(Cc2ccccc2)Cc2cncs2)CC1)C(=O)O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 9.25 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile